FBLG: Phase 1/2 Trial in Diabetic Foot Ulcers to Initiate in 1Q26

FBLG READ THE FULL FBLG RESEARCH REPORT Business Update Approval from HREC for Phase 1/2 Diabetic Foot Ulcer Trial In ...
News Medical

SolasCure demonstrates proof-of-concept in Phase lla safety trial of Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a hydrogel containing tarumase (provisional INN), a recombinant enzyme derived from maggots, and which aims to accelerate wound ...
News Medical

SolasCure enrols first patient in a next phase II clinical trial to advance Aurase Wound Gel

SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound healing, today announced the initiation of a new Phase II clinical trial, CLEANVLU2. The ...
Business Wire

SolasCure Publishes Phase IIa Clinical Trial Report in Leading Wound Care Journal

CAMBRIDGE, England--(BUSINESS WIRE)--SOLASCURE Ltd (SolasCure), a biotechnology company developing a novel treatment to transform chronic wound care, has today announced the publication of its ...
GEN

Wound Healing Fibroblast Dance Led by Fascia-Resident Progenitors

Helmholtz Munich researchers revealed a conserved differentiation process with clinical implications for injury repair, identifying a multipotent fibroblast progenitor in the fascia— the deepest ...
EurekAlert!

Breakthrough research identifies new targets for wound healing

These findings represent a crucial advancement in wound care, paving the way for more effective treatment options and improved patient outcomes. To address this, researchers conducted a study using ...